Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Opioid Settlement topic
No spam. Unsubscribe anytime.
Denton County Commissioners Authorize Participation in National Opioid Settlement, Authorize Judge to Sign Exhibit K
Summary
Denton County Commissioners Court voted unanimously to accept a settlement offer in the National Prescription Opiate Litigation (MDL No. 2804) and authorized the county judge to sign Exhibit K, the secondary manufacturers' combined participation and release form.
After reconvening from executive session, the Denton County Commissioners Court voted unanimously to approve participation in the settlement of the National Prescription Opiate Litigation (MDL No. 2804) and authorized the Denton County judge to sign Exhibit K, the secondary manufacturers' combined subdivision participation and release form.
The motion to accept the settlement offer and to authorize the judge to sign Exhibit K was moved by the chair and seconded by Commissioner Falconer. The court approved the motion without recorded dissent.
The settlement acceptance names multiple defendants in the MDL, including Alvogen Incorporated; Apex Corp.; Amneal Pharmaceuticals LLC; Hikma Pharmaceuticals USA, Inc.; Endeavor, Inc.; Viatris, Inc.; Sun Pharmaceutical Industries, Inc.; and Insitus Pharmaceuticals USA. The litigation is identified in court filings as MDL No. 2804, the National Prescription Opiate Litigation pending in the U.S. District Court for the Northern District of Ohio.
The court also noted that there would be no action taken on agenda item 15(a) following the executive session. With no further business, the court adjourned.
The record shows the chair moved for approval and Commissioner Falconer seconded; the motion carried unanimously, and no roll-call vote listing individual commissioner votes was recorded in the transcript.
